NASDAQ$KMB
Kimberly-Clark Corp · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Kimberly-Clark's Q2 2021 results were announced, showing a mixed performance with sales increase but earnings decline due to higher input costs and consumer destocking.
Kimberly-Clark reported a 2% increase in net sales to $4.7 billion, driven by foreign currency and the Softex Indonesia acquisition, but organic sales declined by 3%. Diluted net income per share was $1.19, and adjusted earnings per share were $1.47, both down from the previous year. The company is facing significantly higher input costs and reduced consumer tissue volumes.
- Net sales increased by 2% to $4.7 billion, but organic sales decreased by 3%.
- Diluted net income per share was $1.19, a decrease from $1.99 in the previous year.
- Adjusted earnings per share were $1.47, down from $2.20 in the previous year.
- The company is now targeting a full-year 2021 organic sales decline of 0 to 2% and adjusted earnings per share of $6.65 to $6.90.
Headline financials
Revenue & EPS history
Kimberly-Clark · Revenue · Quarterly
$4.72B
Forward guidance
Kimberly-Clark updated its full-year 2021 outlook, anticipating net sales to increase by 1 to 4% and organic sales to decline by 0 to 2%. Adjusted earnings per share are expected to be $6.65 to $6.90.
Tailwinds
- Net sales increase 1 to 4 percent.
- Foreign currency exchange rates favorable between 1 and 2 percent.
- Softex Indonesia acquisition expected to increase sales 2 percent.
- Cost savings of $520 to $560 million.
- Capital spending of $1,100 to $1,200 million.
Headwinds
- Organic sales decline 0 to 2 percent.
- Adjusted operating profit expected to decline 11 to 14 percent year-on-year.
- Key cost inputs expected to increase $1,200 to $1,300 million.
- Net income from equity companies similar, to down somewhat, year-on-year.
- Share repurchase of $400 to $450 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-0.1%
Avg return
Earnings day
-1.0%
Avg return
5 days after
+0.7%
Avg return
30 days after
48%
35 / 73 earnings
Positive
+12.0%
Q1 2022
Best reaction
-7.8%
Q3 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -0.6% | +1.0% | |
| Q4 2025 | -0.7% | -1.1% | +9.1% | |
| Q3 2025 | +3.1% | -13.8% | -6.5% | |
| Q2 2025 | +4.8% | +9.7% | +3.6% | |
| Q1 2025 | -1.5% | -6.0% | -0.2% | |
| Q4 2024 | -1.5% | -1.1% | +6.7% | |
| Q3 2024 | -5.1% | -6.0% | -5.0% | |
| Q2 2024 | -2.5% | -1.6% | +0.3% | |
| Q1 2024 | +6.9% | +4.9% | +2.3% | |
| Q4 2023 | -3.6% | -2.9% | -2.6% | |
| Q3 2023 | -2.5% | -4.1% | +0.4% | |
| Q2 2023 | -3.8% | -4.9% | -6.3% | |
| Q1 2023 | +0.8% | +1.7% | -3.8% | |
| Q4 2022 | -3.2% | -4.2% | -6.3% | |
| Q3 2022 | +3.8% | +7.3% | +15.7% | |
| Q2 2022 | -1.0% | -1.2% | -0.4% | |
| Q1 2022 | +12.0% | +9.7% | +0.2% | |
| Q4 2021 | -1.5% | -1.4% | -5.6% | |
| Q3 2021 | +0.2% | -2.7% | +1.6% | |
| Q2 2021 | +0.1% | -0.0% | +2.4% | |
| Q1 2021 | -7.0% | -7.6% | -5.7% | |
| Q4 2020 | +3.7% | -0.1% | -1.1% | |
| Q3 2020 | -7.8% | -9.2% | -5.8% | |
| Q2 2020 | +2.1% | +4.5% | +9.0% | |
| Q1 2020 | +0.6% | +0.6% | +0.2% | |
| Q4 2019 | -0.7% | +0.3% | -2.1% | |
| Q3 2019 | -3.5% | -3.6% | -4.2% | |
| Q2 2019 | +0.3% | +2.2% | +5.6% | |
| Q1 2019 | +1.7% | +1.8% | +6.0% | |
| Q4 2018 | -3.3% | -6.2% | +3.4% | |
| Q3 2018 | -5.5% | -7.2% | +0.4% | |
| Q2 2018 | +0.9% | +2.5% | +10.2% | |
| Q1 2018 | +0.4% | +4.5% | +4.5% | |
| Q4 2017 | +2.4% | +4.6% | -3.5% | |
| Q3 2017 | -1.2% | -0.9% | +2.3% | |
| Q2 2017 | -1.3% | -1.1% | -2.3% | |
| Q1 2017 | +2.2% | -0.2% | -1.5% | |
| Q4 2016 | +4.3% | +3.4% | +14.8% | |
| Q3 2016 | -4.9% | -4.2% | -4.2% | |
| Q2 2016 | -1.7% | -3.8% | -4.4% | |
| Q1 2016 | -4.2% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | +3.1% | — | — | |
| Q2 2015 | -0.3% | — | — | |
| Q1 2015 | +4.2% | — | — | |
| Q4 2014 | -7.7% | — | — | |
| Q3 2014 | +4.3% | — | — | |
| Q2 2014 | -2.5% | — | — | |
| Q1 2014 | -3.7% | — | — | |
| Q4 2013 | +1.9% | — | — | |
| Q3 2013 | +6.2% | — | — | |
| Q2 2013 | -1.3% | — | — | |
| Q1 2013 | +4.2% | — | — | |
| Q4 2012 | +0.3% | — | — | |
| Q3 2012 | -3.6% | — | — | |
| Q2 2012 | +4.7% | — | — | |
| Q1 2012 | +1.8% | — | — | |
| Q4 2011 | -0.1% | — | — | |
| Q3 2011 | +0.7% | — | — | |
| Q2 2011 | -0.3% | — | — | |
| Q1 2011 | -0.6% | — | — | |
| Q4 2010 | -0.4% | — | — | |
| Q3 2010 | -1.4% | — | — | |
| Q2 2010 | +1.1% | — | — | |
| Q1 2009 | +3.0% | — | — | |
| Q1 2010 | -1.0% | — | — | |
| Q4 2007 | +0.0% | — | — | |
| Q4 2009 | +0.0% | — | — | |
| Q4 2008 | +0.9% | — | — | |
| Q3 2008 | +0.9% | — | — | |
| Q3 2009 | +0.9% | — | — | |
| Q2 2009 | -0.0% | — | — | |
| Q2 2008 | -0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro